We are live on ! Find out more
Citadel Advisors

Citadel Advisors Portfolio holdings

AUM $618B
1-Year Est. Return 30.34%
 

Citadel Advisors, founded in 1990 by Kenneth C. Griffin as Citadel LLC and headquartered in Chicago, Illinois, is one of the world’s most prominent hedge funds, managing tens of billions in assets through sophisticated quantitative trading strategies. The firm excels in market-making and high-frequency trading across asset classes like equities, fixed income, options, and commodities, leveraging cutting-edge technology and data analysis to generate returns. Citadel operates two main arms: its hedge fund business, which serves institutional and high-net-worth investors, and Citadel Securities, a leading market maker that facilitates a significant portion of U.S. equity and options trades. Known for its secretive, high-performance culture, Citadel has grown into a financial titan under Griffin’s leadership, influencing global markets with its scale and innovation.

This Fund
S&P 500
This Quarter Est. Return
+7.39%
1 Year Est. Return
+30.34%
3 Year Est. Return
+94.87%
5 Year Est. Return
+105.94%
10 Year Est. Return
+433.28%
AUM
$99.5B
AUM Growth
+$9.81B
Cap. Flow
-$88.8M
Cap. Flow %
-0.09%
Top 10 Hldgs %
21.8%
Holding
8,433
New
1,668
Increased
2,795
Reduced
2,486
Closed
1,259

Sector Composition

Rank Sector Weight
1 Technology 6.18%
2 Consumer Discretionary 5.22%
3 Financials 4.55%
4 Healthcare 4.43%
5 Industrials 4.08%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
GEVO icon
6976
CALL
Gevo
GEVO
$372M
$6K ﹤0.01%
+33
New +$7.18K
CDMO
6977
CALL
DELISTED
Avid Bioservices, Inc. Common Stock
CDMO
$6K ﹤0.01%
1,986
+472
+31% +$1.27K
AXN
6978
DELISTED
Aoxing Pharmaceutical Company Inc.
AXN
$6K ﹤0.01%
10,168
-10,156
-50% -$6.83K
VRDN icon
6979
Viridian Therapeutics
VRDN
$2.2B
$5K ﹤0.01%
45
-110
-71% -$12.3K
NVCN
6980
DELISTED
Neovasc Inc.
NVCN
0
CTIC
6981
CALL
DELISTED
CTI BioPharma Corp. (DE) Common Stock
CTIC
$5K ﹤0.01%
+1,260
New +$4.59K
SEEL
6982
CALL
DELISTED
Seelos Therapeutics, Inc. Common Stock
SEEL
0
TLOG
6983
DELISTED
TetraLogic Pharmaceuticals Corporation
TLOG
$4K ﹤0.01%
+27,442
New +$6.34K
WGA
6984
DELISTED
AG&E Holdings Inc
WGA
$4K ﹤0.01%
15,502
+1,185
+8% +$330
MGH
6985
DELISTED
Minco Gold Corp
MGH
$3K ﹤0.01%
11,437
-179,931
-94% -$54.2K
AADR icon
6986
AdvisorShares Dorsey Wright ADR ETF
AADR
$39.6M
-30,110
Closed -$1.17M
AAT
6987
American Assets Trust
AAT
$1.48B
-48,126
Closed -$2.04M
AAXJ icon
6988
iShares MSCI All Country Asia ex Japan ETF
AAXJ
$3.65B
-50,225
Closed -$2.75M
ABEV icon
6989
PUT
Ambev
ABEV
$48.2B
-29,400
Closed -$174K
ABG icon
6990
PUT
Asbury Automotive
ABG
$4.34B
-6,400
Closed -$338K
ACGL icon
6991
PUT
Arch Capital
ACGL
$34.5B
-8,700
Closed -$209K
ACLS icon
6992
Axcelis
ACLS
$3.85B
-10,207
Closed -$110K
ACNT icon
6993
Ascent Industries
ACNT
$140M
-16,432
Closed -$126K
ACTG icon
6994
Acacia Research
ACTG
$426M
-10,392
Closed -$46K
ACWI icon
6995
iShares MSCI ACWI ETF
ACWI
$32.7B
-85,140
Closed -$4.97M
ZNB
6996
Zeta Network Group
ZNB
$656K
0
-$24K
ADM icon
6997
Archer Daniels Midland
ADM
$38.9B
-164,220
Closed -$7.1M
AEHR icon
6998
Aehr Test Systems
AEHR
$2.51B
-12,012
Closed -$19K
AFK icon
6999
VanEck Africa Index ETF
AFK
$99.1M
-41,390
Closed -$830K
AGG icon
7000
iShares Core US Aggregate Bond ETF
AGG
$138B
-24,592
Closed -$2.77M

Similar funds

Citadel Advisors's Q3 2016 Portfolio in Review

As of Q3 2016, Citadel Advisors held 8,433 positions worth $99.5B, up 11% from $89.7B the previous quarter. Its ten largest holdings account for 22% of the portfolio.

Citadel Advisors's Q3 2016 filing shows 1,668 new, 2,795 increased, 2,486 reduced and 1,259 closed positions. Its largest new stake was Alphabet (Google) Class A: 12,706,900 shares worth $511M. The largest sale was Fidelity National Information Services, an estimated $391M.

By sector, the portfolio is most concentrated in Technology at 6.2% of assets, down from 6.3% a quarter earlier, followed by Consumer Discretionary and Financials.

  • Citadel Advisors's largest Q3 2016 buy was Alphabet (Google) Class A: 12,706,900 shares worth $511M.
  • Citadel Advisors added most to State Street SPDR S&P 500 ETF Trust in Q3 2016, an estimated $742M increase.
  • Citadel Advisors's biggest Q3 2016 reduction was Fidelity National Information Services, cutting an estimated $391M.
  • Citadel Advisors fully exited Lockheed Martin in Q3 2016, selling an estimated $165M.
  • Citadel Advisors's ten largest holdings make up 22% of its $99.5B portfolio in Q3 2016.
  • Citadel Advisors opened 1,668 new positions and closed 1,259 in Q3 2016.
  • Citadel Advisors's portfolio value rose 11% quarter-over-quarter to $99.5B.

Based on Citadel Advisors's 13F filing for Q3 2016, filed 10 Nov 2016.